Wittes J - Search Results

1

Data monitoring committees: Promoting best practices to address emerging challenges.

Fleming TR, DeMets DL, Roe MT, Wittes J, Calis KA, Vora AN, Meisel A, Bain RP, Konstam MA, Pencina MJ, Gordon DJ, Mahaffey KW, Hennekens CH, Neaton JD, Pearson GD, Andersson TL, Pfeffer MA, Ellenberg SS. Fleming TR, et al. Among authors: wittes j. Clin Trials. 2017 Apr;14(2):115-123. doi: 10.1177/1740774516688915. Epub 2017 Feb 1. Clin Trials. 2017. PMID: 28359194 Free PMC article.

2

Change in physician perspective on cholesterol and heart disease. Results from two national surveys.

Schucker B, Wittes JT, Cutler JA, Bailey K, Mackintosh DR, Gordon DJ, Haines CM, Mattson ME, Goor RS, Rifkind BM. Schucker B, et al. Among authors: wittes jt. JAMA. 1987 Dec 25;258(24):3521-6. JAMA. 1987. PMID: 3682155

3

Approached to monitoring the results of long-term disease prevention trials: examples from the Women's Health Initiative.

Freedman L, Anderson G, Kipnis V, Prentice R, Wang CY, Rossouw J, Wittes J, DeMets D. Freedman L, et al. Among authors: wittes j. Control Clin Trials. 1996 Dec;17(6):509-25. doi: 10.1016/s0197-2456(96)00016-5. Control Clin Trials. 1996. PMID: 8974210

4

Considerations in the evaluation of surrogate endpoints in clinical trials. summary of a National Institutes of Health workshop.

De Gruttola VG, Clax P, DeMets DL, Downing GJ, Ellenberg SS, Friedman L, Gail MH, Prentice R, Wittes J, Zeger SL. De Gruttola VG, et al. Among authors: wittes j. Control Clin Trials. 2001 Oct;22(5):485-502. doi: 10.1016/s0197-2456(01)00153-2. Control Clin Trials. 2001. PMID: 11578783

5

Toward protecting the safety of participants in clinical trials.

Califf RM, Morse MA, Wittes J, Goodman SN, Nelson DK, DeMets DL, Iafrate RP, Sugarman J. Califf RM, et al. Among authors: wittes j. Control Clin Trials. 2003 Jun;24(3):256-71. doi: 10.1016/s0197-2456(03)00005-9. Control Clin Trials. 2003. PMID: 12757992

6

Forming your phase III trial's data and safety monitoring board: a perspective on safety.

Wittes J. Wittes J. J Investig Med. 2004 Nov;52(7):453-8. doi: 10.1136/jim-52-07-37. J Investig Med. 2004. PMID: 15651261

7

Liability issues for data monitoring committee members.

DeMets DL, Fleming TR, Rockhold F, Massie B, Merchant T, Meisel A, Mishkin B, Wittes J, Stump D, Califf R. DeMets DL, et al. Among authors: wittes j. Clin Trials. 2004;1(6):525-31. doi: 10.1191/1740774504cn54oa. Clin Trials. 2004. PMID: 16279293

8

Monitoring the randomized trials of the Women's Health Initiative: the experience of the Data and Safety Monitoring Board.

Wittes J, Barrett-Connor E, Braunwald E, Chesney M, Cohen HJ, Demets D, Dunn L, Dwyer J, Heaney RP, Vogel V, Walters L, Yusuf S. Wittes J, et al. Clin Trials. 2007;4(3):218-34. doi: 10.1177/1740774507079439. Clin Trials. 2007. PMID: 17715247

9

Some practical problems in implementing randomization.

Downs M, Tucker K, Christ-Schmidt H, Wittes J. Downs M, et al. Among authors: wittes j. Clin Trials. 2010 Jun;7(3):235-45. doi: 10.1177/1740774510368300. Clin Trials. 2010. PMID: 20484491

10

What information should a sponsor of a randomized trial receive during its conduct?

Anand SS, Wittes J, Yusuf S. Anand SS, et al. Among authors: wittes j. Clin Trials. 2011 Dec;8(6):716-9. doi: 10.1177/1740774511424421. Epub 2011 Oct 24. Clin Trials. 2011. PMID: 22024103

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

248 results

Search Page